mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
0.041 |
0.4 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
BMS-536924 |
GDSC1000 |
pan-cancer |
AAC |
0.025 |
0.4 |
mRNA |
TPCA-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.022 |
0.4 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.4 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |